M R Torloni
Overview
Explore the profile of M R Torloni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Widmer M, Tuncalp O, Torloni M, Oladapo O, Bucagu M, Gulmezoglu A
BJOG
. 2018 May;
125(12):1502-1503.
PMID: 29729217
No abstract available.
2.
Lobo T, Torloni M, Mattar R, Nakamura M, Alexandre S, Daher S
J Endocrinol Invest
. 2018 Apr;
42(2):149-156.
PMID: 29696612
Purpose: The study of adipokines in overweight women with early-onset (diagnosed before 20 weeks) gestational diabetes mellitus (GDM) could help to understand the ethiopathological mechanisms of this disorder. Our aim...
3.
Boatin A, Cullinane F, Torloni M, Betran A
BJOG
. 2017 Jun;
125(1):36-42.
PMID: 28602031
Background: In most regions worldwide, caesarean section (CS) rates are increasing. In these settings, new strategies are needed to reduce CS rates. Objectives: To identify, critically appraise and synthesise studies...
4.
Morisaki N, Ganchimeg T, Vogel J, Zeitlin J, Cecatti J, Souza J, et al.
BJOG
. 2017 Feb;
124(9):1346-1354.
PMID: 28220656
Objective: To evaluate the extent to which stillbirths affect international comparisons of preterm birth rates in low- and middle-income countries. Design: Secondary analysis of a multi-country cross-sectional study. Setting: 29...
5.
Malachias M, Figueiredo C, Sass N, Antonello I, Torloni M, Bortolotto M
Arq Bras Cardiol
. 2016 Nov;
107(3 Suppl 3):49-52.
PMID: 27819388
No abstract available.
6.
Torloni M, Gomes Freitas C, Kartoglu U, Gulmezoglu A, Widmer M
BJOG
. 2016 Mar;
123(13):2076-2086.
PMID: 27006180
Background: Oxytocin is the drug of choice for preventing and treating postpartum haemorrhage, an important cause of maternal death. Oxytocin is widely available in low and middle-income countries (LMIC) but...
7.
Betran A, Torloni M, Zhang J, Gulmezoglu A
BJOG
. 2015 Dec;
123(5):667-70.
PMID: 26681211
No abstract available.
8.
Ye J, Zhang J, Mikolajczyk R, Torloni M, Gulmezoglu A, Betran A
BJOG
. 2015 Sep;
123(5):745-53.
PMID: 26331389
Objective: Caesarean section was initially performed to save the lives of the mother and/or her baby. Caesarean section rates have risen substantially worldwide over the past decades. In this study,...
9.
Souza J, Betran A, Dumont A, De Mucio B, Gibbs Pickens C, Deneux-Tharaux C, et al.
BJOG
. 2015 Aug;
123(3):427-36.
PMID: 26259689
Objective: To generate a global reference for caesarean section (CS) rates at health facilities. Design: Cross-sectional study. Setting: Health facilities from 43 countries. Population/sample: Thirty eight thousand three hundred and...
10.
Daher S, Akita P, Tobinaga C, Pendeloski K, Gueuvoghlanian-Silva B, Torloni M, et al.
Pregnancy Hypertens
. 2015 Jun;
2(3):302.
PMID: 26105437
Introduction: The pathogenesis of preeclampsia (PE) is complex and involves many mechanisms, including impaired placental angiogenesis. Endoglin (Eng) promotes angiogenesis, but in its soluble form (sEng) it is antiangiogenic and...